$BSX
BOSTON SCIENTIFIC CORP

2024 Q4 Form 10-Q Financial Statement

#000088572524000073 Filed on November 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $4.209B
YoY Change 19.34%
Cost Of Revenue $1.317B
YoY Change 19.62%
Gross Profit $2.892B
YoY Change 19.21%
Gross Profit Margin 68.71%
Selling, General & Admin $1.562B
YoY Change 25.76%
% of Gross Profit 54.01%
Research & Development $407.0M
YoY Change 14.33%
% of Gross Profit 14.07%
Depreciation & Amortization $205.0M
YoY Change 120.43%
% of Gross Profit 7.09%
Operating Expenses $2.151B
YoY Change 24.12%
Operating Profit $741.0M
YoY Change 6.93%
Interest Expense -$79.00M
YoY Change -219.7%
% of Operating Profit -10.66%
Other Income/Expense, Net $15.00M
YoY Change -118.07%
Pretax Income $669.0M
YoY Change 9.67%
Income Tax $200.0M
% Of Pretax Income 29.9%
Net Earnings $469.0M
YoY Change -6.94%
Net Earnings / Revenue 11.14%
Basic Earnings Per Share $0.32
Diluted Earnings Per Share $0.32
COMMON SHARES
Basic Shares Outstanding 1.474B shares 1.473B shares
Diluted Shares Outstanding 1.487B shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.502B
YoY Change 162.82%
Cash & Equivalents $2.502B
Short-Term Investments
Other Short-Term Assets $674.0M
YoY Change -9.04%
Inventory $2.753B
Prepaid Expenses
Receivables $2.501B
Other Receivables $0.00
Total Short-Term Assets $8.761B
YoY Change 34.7%
LONG-TERM ASSETS
Property, Plant & Equipment $3.072B
YoY Change 16.58%
Goodwill $15.03B
YoY Change 10.47%
Intangibles $5.754B
YoY Change -1.62%
Long-Term Investments $256.0M
YoY Change 16.36%
Other Assets $1.642B
YoY Change 2.31%
Total Long-Term Assets $29.32B
YoY Change 6.46%
TOTAL ASSETS
Total Short-Term Assets $8.761B
Total Long-Term Assets $29.32B
Total Assets $38.08B
YoY Change 11.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $907.0M
YoY Change -2.37%
Accrued Expenses $2.460B
YoY Change 9.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $1.652B
YoY Change 222.03%
Total Short-Term Liabilities $5.910B
YoY Change 29.07%
LONG-TERM LIABILITIES
Long-Term Debt $9.233B
YoY Change 10.1%
Other Long-Term Liabilities $1.841B
YoY Change -0.91%
Total Long-Term Liabilities $1.841B
YoY Change -0.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.910B
Total Long-Term Liabilities $1.841B
Total Liabilities $7.751B
YoY Change 20.41%
SHAREHOLDERS EQUITY
Retained Earnings $2.107B
YoY Change 568.89%
Common Stock $20.98B
YoY Change 1.89%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.251B
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $20.71B
YoY Change
Total Liabilities & Shareholders Equity $38.08B
YoY Change 11.85%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $469.0M
YoY Change -6.94%
Depreciation, Depletion And Amortization $205.0M
YoY Change 120.43%
Cash From Operating Activities $1.002B
YoY Change 43.35%
INVESTING ACTIVITIES
Capital Expenditures $179.0M
YoY Change -5.79%
Acquisitions
YoY Change
Other Investing Activities -$1.248B
YoY Change 17728.57%
Cash From Investing Activities -$1.427B
YoY Change 624.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.000M
YoY Change -56.25%
NET CHANGE
Cash From Operating Activities 1.002B
Cash From Investing Activities -1.427B
Cash From Financing Activities 7.000M
Net Change In Cash -418.0M
YoY Change -180.69%
FREE CASH FLOW
Cash From Operating Activities $1.002B
Capital Expenditures $179.0M
Free Cash Flow $823.0M
YoY Change 61.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000885725
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2695240
dei Entity Address Address Line1
EntityAddressAddressLine1
300 Boston Scientific Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Marlborough
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Local Phone Number
LocalPhoneNumber
683-4000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.01
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1473827485 shares
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4209000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3527000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12186000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10515000000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1312000000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1101000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3791000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3198000000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
2897000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4372000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3811000000 usd
CY2024Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
407000000 usd
CY2023Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
356000000 usd
us-gaap Interest Expense
InterestExpense
200000000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-78000000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
669000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
610000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1697000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1480000000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
413000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
392000000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
468000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
504000000 usd
us-gaap Profit Loss
ProfitLoss
1284000000 usd
us-gaap Profit Loss
ProfitLoss
1088000000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1464500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1470600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1448800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1484500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1459100000 shares
CY2024Q3 us-gaap Profit Loss
ProfitLoss
468000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
504000000 usd
us-gaap Profit Loss
ProfitLoss
1284000000 usd
us-gaap Profit Loss
ProfitLoss
1088000000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-181000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
21000000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-79000000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-100000000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01752-1234
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
105000000 usd
CY2024Q3 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2023Q3 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
23000000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
469000000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
505000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1288000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1065000000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.74
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1472700000 shares
CY2023Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
3000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10515000000 usd
CY2023Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1000000 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
620000000 usd
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
BOSTON SCIENTIFIC CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei City Area Code
CityAreaCode
508
CY2023Q3 us-gaap Gross Profit
GrossProfit
2426000000 usd
us-gaap Gross Profit
GrossProfit
8395000000 usd
us-gaap Gross Profit
GrossProfit
7317000000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1562000000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1242000000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1156000000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1051000000 usd
CY2024Q3 us-gaap Royalty Expense
RoyaltyExpense
5000000 usd
CY2023Q3 us-gaap Royalty Expense
RoyaltyExpense
11000000 usd
us-gaap Royalty Expense
RoyaltyExpense
24000000 usd
us-gaap Royalty Expense
RoyaltyExpense
35000000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
205000000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
208000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
631000000 usd
CY2024Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
276000000 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
58000000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-23000000 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12000000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-4000000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
43000000 usd
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
8000000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
15000000 usd
us-gaap Restructuring Charges
RestructuringCharges
12000000 usd
us-gaap Restructuring Charges
RestructuringCharges
51000000 usd
CY2024Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2023Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-111000000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-111000000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2164000000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1733000000 usd
us-gaap Operating Expenses
OperatingExpenses
6467000000 usd
us-gaap Operating Expenses
OperatingExpenses
5558000000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
733000000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
693000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1928000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1759000000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
79000000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
66000000 usd
us-gaap Interest Expense
InterestExpense
225000000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1487400000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1475000000 shares
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-95000000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-25000000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
0 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
5000000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-282000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
23000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-173000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-37000000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
187000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
528000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1110000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1051000000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-10000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
16000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-4000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
16000000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-10000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
16000000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
16000000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
177000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
511000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1110000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1035000000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2502000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
865000000 usd
CY2024Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
2501000000 usd
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
2228000000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2753000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2484000000 usd
CY2024Q3 us-gaap Prepaid Taxes
PrepaidTaxes
332000000 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
315000000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
674000000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
621000000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
8761000000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6514000000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3072000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2859000000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
15033000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
14387000000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5754000000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6003000000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3816000000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3841000000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1642000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1531000000 usd
CY2024Q3 us-gaap Assets
Assets
38078000000 usd
CY2023Q4 us-gaap Assets
Assets
35136000000 usd
CY2024Q3 us-gaap Debt Current
DebtCurrent
1652000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
531000000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
907000000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
942000000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2460000000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2646000000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
891000000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
814000000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5910000000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4933000000 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
9233000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
8571000000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
138000000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
134000000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1841000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1967000000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1729000224 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
17000000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
17000000 usd
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
263289848 shares
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
263289848 shares
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
2251000000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2251000000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20963000000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
20647000000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2107000000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
819000000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-128000000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
49000000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
20708000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
19282000000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
248000000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
248000000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20956000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19530000000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38078000000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
35136000000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
20708000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18886000000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
20708000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
18886000000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20956000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19129000000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20956000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
19129000000 usd
us-gaap Profit Loss
ProfitLoss
1284000000 usd
us-gaap Profit Loss
ProfitLoss
1088000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
921000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
883000000 usd
bsx Cash Flow Impact Of Deferred Income Tax Expense Benefit
CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
10000000 usd
bsx Cash Flow Impact Of Deferred Income Tax Expense Benefit
CashFlowImpactOfDeferredIncomeTaxExpenseBenefit
-74000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
197000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
174000000 usd
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
276000000 usd
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
58000000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-60000000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-48000000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-4000000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
43000000 usd
bsx Inventory Step Up Amortization
InventoryStepUpAmortization
0 usd
bsx Inventory Step Up Amortization
InventoryStepUpAmortization
6000000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
22000000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
33000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
261000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
164000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
274000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
601000000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
109000000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
43000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-142000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
95000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1979000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1546000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
513000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
444000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1222000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1018000000 usd
bsx Proceeds From Payments For Investments And Acquisitions Of Certain Technologies
ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies
264000000 usd
bsx Proceeds From Payments For Investments And Acquisitions Of Certain Technologies
ProceedsFromPaymentsForInvestmentsAndAcquisitionsOfCertainTechnologies
89000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-16000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-23000000 usd
us-gaap Payments For Proceeds From Hedge Investing Activities
PaymentsForProceedsFromHedgeInvestingActivities
0 usd
us-gaap Payments For Proceeds From Hedge Investing Activities
PaymentsForProceedsFromHedgeInvestingActivities
-2000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1983000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1521000000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
131000000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
39000000 usd
bsx Payments For Royalty Rights
PaymentsForRoyaltyRights
26000000 usd
bsx Payments For Royalty Rights
PaymentsForRoyaltyRights
50000000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
25000000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
504000000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
22000000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
0 usd
us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
-4000000 usd
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
2145000000 usd
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
28000000 usd
bsx Paymenttonetsharesettleemployeeequityawards
Paymenttonetsharesettleemployeeequityawards
83000000 usd
bsx Paymenttonetsharesettleemployeeequityawards
Paymenttonetsharesettleemployeeequityawards
54000000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
202000000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
165000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1600000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-8000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1594000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1055000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1126000000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2649000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1132000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
197000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
174000000 usd
bsx Fair Value Of Contingent Consideration Recorded In Purchase Accounting
FairValueOfContingentConsiderationRecordedInPurchaseAccounting
29000000 usd
bsx Fair Value Of Contingent Consideration Recorded In Purchase Accounting
FairValueOfContingentConsiderationRecordedInPurchaseAccounting
0 usd
CY2024Q3 bsx Noncashimpactoftransferredroyaltyrights
Noncashimpactoftransferredroyaltyrights
-16000000 usd
CY2023Q3 bsx Noncashimpactoftransferredroyaltyrights
Noncashimpactoftransferredroyaltyrights
-23000000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2502000000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
952000000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
70000000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
123000000 usd
CY2024Q3 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
78000000 usd
CY2023Q3 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
58000000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2649000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1132000000 usd
CY2023Q1 us-gaap Cash
Cash
140000000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
404000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
29000000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-4000000 usd
bsx Payment Of Contingent Consideration
PaymentOfContingentConsideration
258000000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
171000000 usd
CY2024Q3 bsx Uncapped Contingent Considertation
UncappedContingentConsidertation
139000000 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
256000000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
219000000 usd
CY2024Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
276000000 usd
CY2023Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
194000000 usd
CY2024Q3 us-gaap Investments
Investments
532000000 usd
CY2023Q4 us-gaap Investments
Investments
413000000 usd
CY2024Q3 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
255000000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16181000000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10521000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15817000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9988000000 usd
CY2024Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
94000000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
174000000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
14387000000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
633000000 usd
us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
12000000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
15033000000 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
276000000 usd
CY2023Q3 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1000000 usd
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
58000000 usd
CY2024Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
7477000000 usd
CY2023Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
6896000000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1312000000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
79000000 usd
CY2024Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-14000000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
79000000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1101000000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
66000000 usd
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
18000000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
66000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3791000000 usd
us-gaap Interest Expense
InterestExpense
225000000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
7000000 usd
us-gaap Interest Expense
InterestExpense
225000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3198000000 usd
us-gaap Interest Expense
InterestExpense
200000000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
78000000 usd
us-gaap Interest Expense
InterestExpense
200000000 usd
CY2024Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
188000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
266000000 usd
CY2024Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1087000000 usd
CY2023Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
1050000000 usd
CY2024Q3 us-gaap Cash
Cash
803000000 usd
CY2023Q4 us-gaap Cash
Cash
411000000 usd
CY2024Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
10734000000 usd
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
8735000000 usd
CY2024Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
10885000000 usd
CY2023Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
9102000000 usd
CY2024Q3 us-gaap Debt Current
DebtCurrent
1652000000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
531000000 usd
CY2024Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
9233000000 usd
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
8571000000 usd
bsx Qualified Acquisition Consideration
QualifiedAcquisitionConsideration
1000000000.000 usd
CY2024Q3 bsx Amount Excluded From Debt In Leverage Ratio
AmountExcludedFromDebtInLeverageRatio
2218000000 usd
CY2024Q3 bsx Exclusion From Ebitda For Restructuring Charges
ExclusionFromEbitdaForRestructuringCharges
500000000 usd
CY2024Q3 bsx Restructuring Charges Remaining To Be Excluded From Calculation Of Consolidated Ebitda
RestructuringChargesRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
401000000 usd
CY2024Q3 bsx Litigation Payment Exclusion From Ebitda
LitigationPaymentExclusionFromEBITDA
1000000000.000 usd
CY2024Q3 bsx Legal Payments Remaining To Be Excluded From Calculation Of Consolidated Ebitda
LegalPaymentsRemainingToBeExcludedFromCalculationOfConsolidatedEbitda
1442000000 usd
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
2145000000 usd
CY2024Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
216000000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
174000000 usd
CY2024Q3 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
137000000 usd
CY2023Q4 us-gaap Supplier Finance Program Obligation Current
SupplierFinanceProgramObligationCurrent
152000000 usd
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2610000000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2338000000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
109000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
110000000 usd
CY2024Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
2501000000 usd
CY2023Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
2228000000 usd
CY2024Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
105000000 usd
CY2023Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
127000000 usd
CY2023Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
110000000 usd
CY2022Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
109000000 usd
CY2024Q3 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
10000000 usd
CY2023Q3 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
10000000 usd
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
30000000 usd
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
44000000 usd
CY2024Q3 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
6000000 usd
CY2023Q3 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
11000000 usd
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
32000000 usd
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
27000000 usd
CY2024Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
109000000 usd
CY2023Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
126000000 usd
CY2024Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
109000000 usd
CY2023Q3 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
126000000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1687000000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1537000000 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
206000000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
174000000 usd
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
860000000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
773000000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2753000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2484000000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
70000000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
130000000 usd
CY2024Q3 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
168000000 usd
CY2023Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
159000000 usd
CY2024Q3 bsx Licensingarrangements
Licensingarrangements
33000000 usd
CY2023Q4 bsx Licensingarrangements
Licensingarrangements
47000000 usd
CY2024Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
403000000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
285000000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
674000000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
621000000 usd
CY2024Q3 us-gaap Land
Land
143000000 usd
CY2023Q4 us-gaap Land
Land
140000000 usd
CY2024Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1912000000 usd
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1843000000 usd
CY2024Q3 bsx Equipment Furniture And Fixtures Gross
EquipmentFurnitureAndFixturesGross
3673000000 usd
CY2023Q4 bsx Equipment Furniture And Fixtures Gross
EquipmentFurnitureAndFixturesGross
3503000000 usd
CY2024Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
966000000 usd
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
857000000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6694000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6343000000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3622000000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3484000000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3072000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2859000000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
102000000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
93000000 usd
us-gaap Depreciation
Depreciation
290000000 usd
us-gaap Depreciation
Depreciation
263000000 usd
CY2024Q3 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
78000000 usd
CY2023Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
60000000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
426000000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
439000000 usd
CY2024Q3 us-gaap Derivative Assets
DerivativeAssets
20000000 usd
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
107000000 usd
CY2024Q3 us-gaap Investments
Investments
532000000 usd
CY2023Q4 us-gaap Investments
Investments
413000000 usd
CY2024Q3 bsx Licensingarrangementsasset
Licensingarrangementsasset
4000000 usd
CY2023Q4 bsx Licensingarrangementsasset
Licensingarrangementsasset
30000000 usd
CY2024Q3 bsx Indemnification Asset
IndemnificationAsset
183000000 usd
CY2023Q4 bsx Indemnification Asset
IndemnificationAsset
176000000 usd
CY2024Q3 bsx Other Other Longterm Assets
OtherOtherLongtermAssets
400000000 usd
CY2023Q4 bsx Other Other Longterm Assets
OtherOtherLongtermAssets
306000000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1642000000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1531000000 usd
CY2024Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
126000000 usd
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
206000000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1111000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1051000000 usd
CY2024Q3 bsx Accrued Rebates Current
AccruedRebatesCurrent
460000000 usd
CY2023Q4 bsx Accrued Rebates Current
AccruedRebatesCurrent
389000000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
62000000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
304000000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
701000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
696000000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2460000000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2646000000 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
290000000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
266000000 usd
CY2024Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
33000000 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
49000000 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
286000000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
220000000 usd
CY2024Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
282000000 usd
CY2023Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
278000000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
891000000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
814000000 usd
CY2024Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
364000000 usd
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
470000000 usd
CY2024Q3 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
124000000 usd
CY2023Q4 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
172000000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
109000000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
100000000 usd
CY2024Q3 bsx Licensingarrangementsliability
Licensingarrangementsliability
8000000 usd
CY2023Q4 bsx Licensingarrangementsliability
Licensingarrangementsliability
41000000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
373000000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
390000000 usd
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
328000000 usd
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
311000000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
535000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
484000000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1841000000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1967000000 usd
CY2024Q3 bsx Effective Income Tax Rate Reconciliation Reported Tax Rate Percent
EffectiveIncomeTaxRateReconciliationReportedTaxRatePercent
0.300
CY2023Q3 bsx Effective Income Tax Rate Reconciliation Reported Tax Rate Percent
EffectiveIncomeTaxRateReconciliationReportedTaxRatePercent
0.173
bsx Effective Income Tax Rate Reconciliation Reported Tax Rate Percent
EffectiveIncomeTaxRateReconciliationReportedTaxRatePercent
0.244
bsx Effective Income Tax Rate Reconciliation Reported Tax Rate Percent
EffectiveIncomeTaxRateReconciliationReportedTaxRatePercent
0.265
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.123
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.002
us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.060
us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.073
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.177
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.171
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.183
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.192
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
493000000 usd
CY2024Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
417000000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
467000000 usd
CY2023Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
395000000 usd
CY2024Q3 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
9000000 usd
CY2024Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
250000000 usd
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
377000000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
70000000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
130000000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-111000000 usd
CY2023Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
42000000 usd
CY2024Q2 bsx Pre Judgement Interest
PreJudgementInterest
7000000 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1472700000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1464500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1470600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1448800000 shares
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
14800000 shares
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10500000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13900000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10200000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1487400000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1475000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1484500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1459100000 shares
CY2024Q3 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
2000000 shares
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
8000000 shares
CY2023Q3 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
2000000 shares
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
32000000 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2020Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000.000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 reportablesegments
CY2024Q3 bsx Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
30000000 usd
CY2023Q3 bsx Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
28000000 usd
bsx Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
68000000 usd
bsx Impact Of Foreign Currency Fluctuations On Net Sales
ImpactOfForeignCurrencyFluctuationsOnNetSales
130000000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4209000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3527000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12186000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10515000000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
205000000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
208000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
631000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
620000000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
733000000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
693000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1928000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1759000000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-65000000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-83000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-231000000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-279000000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
669000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
610000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1697000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1480000000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5 business
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4209000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3527000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12186000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10515000000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4209000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3527000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12186000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10515000000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
618000000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
577000000 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
57000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
177000000 usd
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0000885725-24-000073-index-headers.html Edgar Link pending
0000885725-24-000073-index.html Edgar Link pending
0000885725-24-000073.txt Edgar Link pending
0000885725-24-000073-xbrl.zip Edgar Link pending
bsx-20240930.htm Edgar Link pending
bsx-20240930.xsd Edgar Link pending
exhibit311-ceo302q32024.htm Edgar Link pending
exhibit312-cfo302q32024.htm Edgar Link pending
exhibit321-ceo906q32024.htm Edgar Link pending
exhibit322-cfo906q32024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
bsx-20240930_cal.xml Edgar Link unprocessable
bsx-20240930_def.xml Edgar Link unprocessable
bsx-20240930_pre.xml Edgar Link unprocessable
bsx-20240930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bsx-20240930_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending